ScholarWorks@Gachon: Park, Kee Hyung

Detailed Information

Park, Kee Hyung (박기형)

College of Medicine (Department of Medicine)

Research Area

Tel 032-460-3346
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

s disease:18||Alzheimer&apos:16||Dementia:10||Obstructive sleep apnea:8||Frontotemporal dementia:5||Polysomnography:5||Alzheimer’s disease:5||dementia:5||Alzheimer Disease:5||Alzheimer's disease:4||mild cognitive impairment:4||hippocampus:3||positron emission tomography:3||Cognition:3||폐쇄성수면무호흡증:3||tau:3||cognition:3||activities of daily living:3||subjective cognitive decline:2||Asia:2||Amyloid:2||neurofibrillary tangles:2||Frontotemporal Dementia:2||Memantine:2||quality of life:2||단순코골이:2||REM sleep behavior disorder:2||Awareness:2||Subjective cognitive decline:2||Activities of daily living:2||Caregivers:2||Korean:2||frontotemporal dementia:2||Genetic Research:2||GRN:2||Pittsburgh sleep quality index:2||MAPT:2||Neuroinflammation:2||magnetic resonance imaging:2||Simple snoring:2||PositronEmission Tomography:2||White matter hyperintensities:2||Cephalometry:2||sleep:2||THK:2||Cognitive Dysfunction:1||Cognitive decline:1||Cognitive neuropsychology:1||Cognitive reserve:1||Cohort study:1||Cutoff value:1||Cystic metastasis:1||DHP1401:1||DRAGON score:1||Dementia support center:1||Depression:1||Disease progression:1||Donepezil:1||Drug Therapy:1||EEG:1||Echocardiography:1||Electrophysiology:1||Encephalopathy:1||Eysenck personality questionnaire:1||Facial nerve fascicle:1||Fluorodeoxyglucose F18:1||Frontal lobe:1||Guideline:1||Guideline for dementia:1||Hypertension:1||Hypoparathyroidism:1||Incidence:1||Inducedhypertension:1||International expert consensus:1||International largedata collaborations:1||Ischemic stroke:1||Korea:1||Lacunar infarction, progression:1||Language:1||Lecanemab:1||Left atrial enlargement:1||Leukoaraiosis:1||Lewy Body Disease:1||Lewy body disease.:1||MRI:1||Machine learning:1||Magnetic Resonance Imaging:1||Magnetic resonance imaging:1||Median nerve:1||Mediation:1||MetaAnalysis:1||Mild cognitive impairment:1||MiniMental State Examination:1||Monoclonal Antibody:1||Motor neuron disease:1||Mutation:1||National health insurance service:1||Neurocysticercosis:1||Neurofibrillary Tangles:1||Neurofibrillary tangles:1||Neurogenic tumor:1||Neuroimaging:1||Neurology:1||Neuropsychological assessment:1||Neuropsychological test:1||Neuropsychology:1||Nextgeneration sequencing:1||OSA 증상 인식:1||Observed apnea:1||Ocular motility:1||PRNP:1||Parkinson disease:1||Parkinsonism:1||Personality characteristics:1||Phenylephrine:1||Pittsburg Sleep Quality Index:1||Pittsburgh Sleep Quality Index:1||Policy:1||Pontine infarction:1||Positron Emission Tomography:1||Positron Emission Tomography Computed Tomography:1||Positron emission tomography:1||Practice Guidelines:1||Prediction formula:1||Prevention:1||Primary Progressive Nonfluent Aphasia:1||Primary progressive aphasia:1||Quality of life:1||Questionnaire:1||REM behavior disorder:1||REM sleep without atonia:1||Rapid eye movement screening questionnaire:1||Rapid eye movement sleep behavior disorder:1||Realworld evidence:1||Religiosity:1||Reversible:1||Reversible cerebral vasoconstriction syndrome:1||Risk Factors:1||SCL90R:1||SIVD:1||SPECT:1||SVD:1||Seizure:1||SelfAssessment:1||SelfReport:1||Sleep:1||Sleep electroencephalography:1||Sleep questionnaire:1||SlowWave:1||Spectral analysis:1||Splenium:1||Standardized datasets:1||Stroke subtype:1||Stroop test:1||Subarachnoid hemorrhage:1||Subjective Cognitive Decline:1||Subtle cognitive impairment:1||Surveys and questionnaires:1||Symptom Checklist90Revised:1||T1weighted axial Visual Rating Scale:1||T2weighted image:1||THK5351:1||Tau:1||Tauopathies:1||Telomere:1||Thunderclap headache:1||Transient ischemic attack:1||Translational Medical Research:1||Unified Parkinson&apos:1||WHOQOLBREF:1||Wernicke&apos:1||White Matter:1||abnormal behavior:1||acetylcholinesterase inhibitor:1||alexia:1||amnestic mild cognitive impairment:1||amyloid:1||amyloid positron emission tomography computed tomography:1||amyloidbeta protein:1||apneahypopnea index:1||apolipoproteinE:1||awareness:1||behavior:1||behavioral symptoms:1||biomarker:1||bloodbrain barrier:1||body mass index:1||brain imaging:1||caregiver:1||caregiver education:1||carers:1||cerebral small vessel disease:1||cerebrovascular disease:1||cilostazol:1||classification:1||clinical trial:1||cluster analysis:1||cluster headache:1||cognitive complaints:1||cognitive function:1||cohort study:1||conversion rate:1||cortical thickness:1||cutoff score:1||depression:1||diagnostic screening program.:1||donepezil transdermal patch:1||donepezil.:1||dopamine agonists:1||early onset Alzheimer&apos:1||earlyonset Alzheimer&apos:1||earlyonset dementia:1||efficacy:1||electroencephalography:1||eligibility:1||executive function:1||fluorodeoxyglucose:1||functional connectivity:1||fusiform gyrus:1||genetics:1||hemiparesis:1||hypometabolism:1||ideogram:1||improvement:1||ischemia:1||lacunar infarct:1||language:1||lateonset Alzheimer&apos:1||lecanemab:1||magnetic resonance imaging.:1||medial temporallobe atrophy:1||memory:1||mer’s disease:1||mild to moderate AD:1||mortality:1||mutation:1||myoclonus:1||neurodegeneration:1||neuropsychology:1||neuropsychometry:1||nextgeneration sequencing:1||nomogram:1||nulticenter study:1||obesity:1||obstructive sleep apnea:1||outcomes:1||parkinsonism:1||phonogram.:1||physical frailty:1||plasma:1||positron emission tomography.:1||positronemission tomography:1||presenilin:1||primary progressive aphasia:1||prognosis:1||questionnaire:1||randomized placebocontrolled clinical trial:1||religion:1||restless legs syndrome:1||s Disease Rating Scale:1||s dementia:1||s encephalopathy:1||safety:1||self report:1||selfassessment:1||semantic variant primary progressive aphasia:1||sequencing:1||simple snoring:1||subcortical ischemic vascular disease:1||subcortical shape analysis:1||subject cognitive decline:1||survival:1||survival analysis:1||tau Protein:1||thrombolysis:1||treatment compliance.:1||visual rating:1||white matter:1||white matter hyperintensities:1||두계골계측:1||램수면장애:1||램수면행동장애:1||성격 특성:1||수면다원검사:1||수면무호흡증·무호흡저호흡지수·수면다원검사·관찰되는 무호흡·체질량지수.:1||수면설문:1||신체계측:1||아이젱크성격검사:1||절단값:1||폐쇄성 수면무호흡증:1||AARS2:1||피츠버그수면질설문:1||AD:1||APOE genotype:1||ASPECTS score:1||Activities daily living:1||Age at symptom onset:1||Alzheimer disease:1||Alzheimer's Disease:1||Alzheimer's disease care:1||Alzheimer’s Disease:1||Amyloidbeta:1||Angina:1||Apnea hypopnea index:1||Apneahypopnea index:1||Apolipoprotein E epsilon 4:1||Atonic:1||Atrophy:1||Autoimmune thyroid disease:1||Awareness of OSA symptoms:1||Behavioral Symptoms:1||Bell’s palsy:1||Biomarker:1||Biomarkers:1||Body mass index:1||Body mass index.:1||Brain volumetry:1||Breathingrelated sleep disorder:1||Burden:1||Butyrylcholinesterase:1||C9orf72:1||CSF1R:1||Calcification:1||Cardiometabolic Risk Factors:1||Cardiovascular accident:1||Caregiver:1||Carpal tunnel syndrome:1||Cerebral Small Vessel Disease:1||Cerebral angiography:1||Cerebral infarct:1||Cerebral infarction:1||Cholinesterase Inhibitors:1||Cilostazol:1||Clinical Trial:1||Clinical practice improvement:1||Cognitive Decline:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE